June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Intratarsal injection of kenacort in the treatment of severe cases of VKC
Author Affiliations & Notes
  • Sihem Lazreg
    Blida, Cabinet Dr Lazreg, Blida, Algeria
  • Didier Renault
    Laboratories thea, Clear not ferrand, France
  • Moncef Khairallah
    University hospital, Monastir, Tunisia
  • Maya Benali abdellah
    Blida, Cabinet Dr Lazreg, Blida, Algeria
  • Footnotes
    Commercial Relationships Sihem Lazreg, None; Didier Renault, None; Moncef Khairallah, None; Maya Benali abdellah, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3066. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sihem Lazreg, Didier Renault, Moncef Khairallah, Maya Benali abdellah; Intratarsal injection of kenacort in the treatment of severe cases of VKC. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3066.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To treat refractory cases of Vkc with intratarsal injections of kenacort

 
Methods
 

We treated Severe cases of Vkc that have already experienced different anti allergic treatments and topical steroids with frequent relapses and dependancies to steroids with intratarsal injection of 40 mg of dexametasone , the follow up visits were performed at D0, D 3, D7 and D30 ( slit lamp examination, corneal staining, ocular pressure )

 
Results
 

60 severe cases of Vkc 45 males , mean age 10,4+/- 3,5years , 90% bilateral , and 100% of corneal involvement . 70% mixed forms and 15% of tarsal forms, the mean follow up was 20+/-7 months . at D3 we had a decrease of all ocular signs (photophobia, redness and pruritis) at D7 decrease of corneal staining and trantas nods, and at d30 , total remission of the Vkc, the mean duration of the efficacy of the treatment was 10.4+/- 2.6 months , no adverse event was observed .

 
Conclusions
 

Intratarsal injection of steroids is very effective in severe and resistant cases of Vkc , especially in our countries where this disease is very severe and frequent and when topical cyclosporine is not available .  

 

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×